Medical management of early pregnancy loss is cost-effective compared with office uterine aspiration.

ABSTRACT:

Background

Early pregnancy loss, also referred to as miscarriage, is common, affecting approximately 1 million people in the United States annually. Early pregnancy loss can be treated with expectant management, medications, or surgical procedures-strategies that differ in patient experience, effectiveness, and cost. One of the medications used for early pregnancy loss treatment, mifepristone, is uniquely regulated by the Food and Drug Administration.

Objective

This study aimed to compare the cost-effectiveness from the healthcare sector perspective of medical management of early pregnancy loss, using the standard of care medication regimen of mifepristone and misoprostol, with that of office uterine aspiration.

Study design

We developed a decision analytical model to

SUBMITTER: Nagendra D 

PROVIDER: S-EPMC10302401 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature